Neogene Therapeutics

Neogene Therapeutics company information, Employees & Contact Information

Neogene Therapeutics is a global, clinical-stage biotechnology company pioneering the discovery, development, and manufacturing of next-generation engineered T cell receptor (TCR) therapies targeting a broad spectrum of solid cancers. With offices in Santa Monica, CA and Amsterdam, the Netherlands, Neogene is aiming to change the paradigm of treatment for solid cancers. Neogene is a member of the AstraZeneca Group.

Company Details

Employees
61
Founded
-
Address
Science Park 106, Amsterdam,north Holland 1098,netherlands
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Amsterdam, North Holland
Looking for a particular Neogene Therapeutics employee's phone or email?

Neogene Therapeutics Questions

News

Neogen Announces Sale of Cleaners & Disinfectants Business - Business Wire

Neogen Announces Sale of Cleaners & Disinfectants Business Business Wire

Neogen® launches Igenity® BCHF to mitigate Bovine Congestive Heart Failure risk - Beef Magazine

Neogen® launches Igenity® BCHF to mitigate Bovine Congestive Heart Failure risk Beef Magazine

AstraZeneca to Acquire Neogene Therapeutics for $320M - citybiz

AstraZeneca to Acquire Neogene Therapeutics for $320M citybiz

Business Spotlight Series: Biotech - Santa monica.gov

Business Spotlight Series: Biotech Santa monica.gov

Neogen® MDS Awarded Contract from USDA Food Safety and Inspection Service - PR Newswire

Neogen® MDS Awarded Contract from USDA Food Safety and Inspection Service PR Newswire

Neogene Therapeutics Raises $110 Million Series A Financing to Develop Next-Generation Fully Personalized Neo-Antigen T Cell Receptor (TCR) Therapies - DutchNews.nl

Neogene Therapeutics Raises $110 Million Series A Financing to Develop Next-Generation Fully Personalized Neo-Antigen T Cell Receptor (TCR) Therapies DutchNews.nl

Neogene Therapeutics Announces Approval of Clinical Trial Application for its First Phase 1 Trial of Novel, Fully-Individualized TCR Therapy to Treat Advanced Solid Tumors - Business Wire

Neogene Therapeutics Announces Approval of Clinical Trial Application for its First Phase 1 Trial of Novel, Fully-Individualized TCR Therapy to Treat Advanced Solid Tumors Business Wire

Top Neogene Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant